Novo Nordisk Gets CDSCO Panel Nod for Rybelsus Label Update, Aligned with EMA
New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has recommended approval of an updated package insert for Rybelsus tablets (3 mg, 7 mg, and 14 mg), manufactured by Novo Nordisk (India) Private Limited. The decision came during the SEC meeting held on August 20, 2025, at CDSCO headquarters […]